Skip to main content
Log in

Extracellular phospholipase A2: causative agent in circulatory collapse of septic shock?

  • Published:
Agents and Actions Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. B. E. Kreger, D. E. Craven, P. C. Carling and W. R. McCabe,Gram-negative bacteremia. Reassessment of etiology, epidemiology and ecology in 612 patients. Am. J. Med.68, 332–343 (1980).

    Article  PubMed  Google Scholar 

  2. J. J. Zimmerman and K. A. Dietrich,Current perspectives on septic shock. Pediatr. Clin. North Am.34, 131–163 (1987).

    PubMed  Google Scholar 

  3. C. L. Sprung, P. V. Caralis, E. H. Marcial et al.,The effects of high-dose corticosteroids in patients with septic shock. N. Engl. J. Med.311, 1137–1143 (1984).

    PubMed  Google Scholar 

  4. K. J. Tracey, B. Beutler, S. F. Lowry, J. Merryweather et al.,Shock and tissue injury induced by recombinant human cachectin. Science234, 470–474 (1986).

    PubMed  Google Scholar 

  5. M. F. Wilson and D. J. Brackett,Release of vasoactive hormones and circulatory changes in shock. Circ. Shock11, 225–234 (1983).

    PubMed  Google Scholar 

  6. A. M. Lefer,Eicosanoids as mediators of ischemia and shock. Federation Proc.44, 275–280 (1985).

    Google Scholar 

  7. P. Vadas, S. Wasi, H. Movat and J. Hay,Extracellular phospholipase A 2 mediates inflammatory hyperemia. Nature273, 583–585 (1981).

    Article  Google Scholar 

  8. P. Vadas and J. Hay,The appearance and significance of phospholipase A 2 in lymph draining tuberculin reactions. Am. J. Pathol.107, 285–291 (1982).

    PubMed  Google Scholar 

  9. P. Vadas and W. Pruzanski,Role of extracellular phospholipase A 2 in inflammation. Adv. Inflamm. Res.7, 51–59 (1984).

    Google Scholar 

  10. R. Franson, R. Dobrow, J. Weiss, P. Elsbach and W. B. Weglicki,Isolation and characterization of a phospholipase A 2 from an inflammatory exudate. J. Lipid Res.19, 18–23 (1978).

    PubMed  Google Scholar 

  11. W. Pruzanski, P. Vadas, E. Stefanski and M. B. Urowitz,Phospholipase A 2 activity in sera and synovial fluids in rheumatoid arthritis and osteoarthritis: its possible role as a proinflammatory enzyme. J. Rheumatol.12, 211–216 (1986).

    Google Scholar 

  12. P. Vadas, E. Stefanski and W. Pruzanski,Characterization of extracellular phospholipase A 2 in rheumatoid synovial fluid. Life Sci.36, 579–587 (1985).

    Article  PubMed  Google Scholar 

  13. E. Stefanski, W. Pruzanski, B. Sternby and P. Vadas,Purification of a soluble phospholipase A 2 from synovial fluid in rheumatoid arthritis. J. Biochem.100, 1297–1303 (1986).

    PubMed  Google Scholar 

  14. W. Pruzanski, E. Keystone and P. Vadas,Serum phospholipase A 2 levels correlate with disease activity in rheumatoid arthritis. Clin. Exp. Immunol., (submitted).

  15. P. Vadas,The efficacy of anti-inflammatory agents with respect to extracellular phospholipase A 2 activity. Life Sci.30, 155–162 (1982).

    Article  PubMed  Google Scholar 

  16. P. Vadas, W. Pruzanski, A. Sos, A. Melcher, H. Jacobs and T. Cheong,Synthesis and secretion of soluble phospholipase A 2 from cultured osteoblasts. Arthr. Rheum.30, (suppl), S65 (1987).

    Google Scholar 

  17. J. Chang, S. Gilman and A. Lewis,Interleukin 1 activates phospholipase A 2 in rabbit chondrocytes: a possible signal for IL-1 action. J. Immunol.136, 1283–1287 (1986).

    PubMed  Google Scholar 

  18. W. Pruzanski, P. Vadas and V. Fornasier,Inflammatory effect of intradermal administration of soluble phospholipase A 2 in rabbits. J. Invest. Dermatol.86, 380–383 (1986).

    Article  PubMed  Google Scholar 

  19. P. Vadas and J. Hay,Secretion of a hyperemia-inducing moiety by mitogen or glycogen-stimulated mononuclear inflammatory cells of sheep and rabbit. Int. Arch. Allergy appl. Immunol.62 142–151 (1980).

    PubMed  Google Scholar 

  20. P. Vadas and J. Hay.Cutaneous blood flow measurements: a standardization of the microsphere assay for yasocative agents. Agents and Actions8, 504–508 (1978).

    PubMed  Google Scholar 

  21. H. Shubin and M.-H. Weil,Bacterial shock, JAMA235, 421–424 (1976).

    Article  PubMed  Google Scholar 

  22. B. Urbaschek and R. Urbaschek,The inflammatory response of endotoxins. Bibl. Ant.17, 74–104 (1979).

    Google Scholar 

  23. P. Vadas and J. Hay,Invovlement of circulating phospholipase A 2 in the pathogenesis of hemodynamic changes in endotoxin shock. Can. J. Physiol. Pharmacol.61, 561–566 (1983).

    PubMed  Google Scholar 

  24. M. Hallman, R. Spragg, J. H. Harrell, K. M. Moser and L. Gluck,Evidence of lung surfactant abnormality in respiratory failure. J. Clin. Invest.70, 673–683 (1982).

    PubMed  Google Scholar 

  25. P. Vadas,Elevated plasma phospholipase A 2 levels: correlation with the hemodynamic and pulmonary changes in gram-negative septic shock. J. Lab. Clin. Med.104, 873–881 (1984).

    PubMed  Google Scholar 

  26. P. Vadas, W. Pruzanski, E. Stefanski, B. Sternby, R. Mustard, J. Bohnen, I. Fraser, V. Farewell and C. Bombardier,The pathogenesis of hypotension in septic shock: correlation of circulating phospholipase A 2 levels with circulatory collapse. Critical Care Med., in press.

  27. P. Vadas and W. Pruzanski,Role of secretory phospholipases A 2 in the pathobiology of disease. Laboratory Invest.55, 391–404 (1986).

    Google Scholar 

  28. R. Flower,Macrocortin and the antiphospholipase proteins. Adv. Inflam. Res.8, 1–34 (1984).

    Google Scholar 

  29. P. Vadas, W. Pruzanski, E. Stefanski, J. Ruse, V. Farewell, J. McLaughlin and C. Bombardier,Concordance of endogenous cortisol and phospholipase A 2 levels in gram-negative septic shock, A prospective study. J. Lab. Clin. Med., in press.

  30. P. McCullagh,Regression models for orindal data. J. Royal Statistical Society.142, 109–142 (1980).

    Google Scholar 

  31. P. Vadas, E. Stefanski and W. Pruzanski,Comparative analysis of assays for phospholipase A 2 activity using biomembrane associated and micellar substrates. The influence of albumin. Inflammation10, 183–193 (1986).

    Article  PubMed  Google Scholar 

  32. P. Vadas, E. Stefanski and W. Pruzanski,Potential therapeutic efficacy of inhibitors of human phospholipase A 2 in septic shock. Agents and Actions19, 194–202 (1986).

    Article  PubMed  Google Scholar 

  33. J. A. Vick and R. B. Brooks,Pharmacological studies of the major fractions of bee venom. Am. Bee J.112, 288–289 (1972).

    Google Scholar 

  34. E. Hebermann,Beiträge zur pharmacologie von phospholipase. A. Arch. Exp. Pathol. Pharmakol.230, 538–546 (1957).

    Google Scholar 

  35. N. A. Marsh and B. C. Whaler,The effects of honey bee venom and two of its constituents, melittin and phospholipase A 2,on the cardiovascular system of the rat. Toxicon,18, 427–435 (1980).

    Article  PubMed  Google Scholar 

  36. K. M. M. Shakir, J. T. O'Brian and S. L. Gartner,Enhanced phospholipase A 2 activity in rat plasma, liver and intestinal mucosa following endotoxin treatment: possible explanation for the protective effect of indomethacin in endotoxic shock. Metabolism34, 176–182 (1985).

    Article  PubMed  Google Scholar 

  37. D. Schmidt and G. E. Hoffmann,Activity of phospholipase A compared in serum of patients with pancreatic and nonpancreatic diseases. Clin. Chem.33, 594–596 (1987).

    PubMed  Google Scholar 

  38. J. T. Flynn, J. M. Henry and W. Perkoswki,Phospholipase A 2 stimulated release of prostanoids from the isolated perfused rabbit liver: implications in regional cellular injury. Can. J. Physiol. Pharmacol.59, 1268–1273 (1981).

    PubMed  Google Scholar 

  39. H. C. Huang,Effects of phospholipases A 2 from Vipera russelli snake venom on blood pressure, plasma prostacyclin level, and renin activity in rats. Toxicon22, 253–264 (1984).

    Article  PubMed  Google Scholar 

  40. C. L. Ho and C. Y. Lee,Cardiovascular effects of phospholipases A 2 purified from various snake venoms. Proc. Natl. Sci. Counc. B. ROC5, 181–189 (1981).

    Google Scholar 

  41. H. C. Huang,Release of slow-reacting substance from the guinea-pig lung by phospholipases A 2 of Vipera russelli snake venom. Toxicon22, 359–372 (1984).

    Article  PubMed  Google Scholar 

  42. F. Hirata, E. Schiffman, K. Venkatasubramanian, D. Solmon and J. Axelrod,A phospholipase A 2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. Proc. Natl. Acad. Sci. USA77, 2533–2536 (1980).

    PubMed  Google Scholar 

  43. G. J. Blackwell, R. Carnuccio, M. DiRosa, R. J. Flower, C. S. J. Langham, L. Parente, P. Persico, N.-C. Russell-Smith and D. StoneGlucocorticoids induced the formation and release of anti-inflammatory and anti-phospholipase proteins into the peritoneal cavity of the rat. Br. J. Pharmacol.76, 185–195 (1982).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by The Arthritis Society and The Wellesley Hospital Research Institute.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vadas, P., Pruzanski, W. & Stefanski, E. Extracellular phospholipase A2: causative agent in circulatory collapse of septic shock?. Agents and Actions 24, 320–325 (1988). https://doi.org/10.1007/BF02028289

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02028289

Keywords